In Search of New Organisational Forms – The Case for Open Innovation and Crowdsourcing by Philbin, SP & Philbin, SP
Proceedings of the American Society for Engineering Management 2014 International Annual Conference
S. Long, E-H. Ng, and C. Downing eds.


[FINAL PAPER ONLY] Author 1, 2, or 3 Last Name






IN SEARCH of new organizational forms – the case for open innovation and crowdsourcing





Organizational forms differ according to structure, processes and resourcing with the majority of such forms having existed for many years.  However, engineering systems and technologies are becoming ever more complex and the question arises: Are there any new organizational forms emerging?  Further, if there are any, what are their characteristics?  This paper will attempt to answer these questions through examining the case for open innovation and crowdsourcing, which are currently two of the most high-profile technology and innovation business models being pursued.  The paper will report on the findings from an exploratory investigation of open innovation in the pharmaceutical industry and crowdsourcing in the product design sector.  Supporting literature has been reviewed as well as background data and information available on these two industry applications of open business models.  The pros and cons for each of the industrial applications have been identified as well as examination of the underlying features.  The findings from the initial research study are that both these industry applications of open innovation and crowdsourcing do potentially represent new organizational forms, which offer significant benefits but also carry certain risks and challenges.
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Introduction
Organizational forms differ according to structure, processes and resourcing with the majority of such forms having existed for many years.  Industrial companies need to be able to adapt to both external dynamics and internal pressures and the ability to modify the existing organizational form or adapt an entirely new form will often be an important factor contributing to a company’s continued success and long term financial sustainability.  However, engineering systems and technologies are becoming ever more complex (Vrabič and Butala, 2011) and are subject to an increasing rate of change; the inevitable question arises: Are there any new organizational forms emerging?  Further, if there are any, what are their characteristics?  Before exploring these questions it is useful to briefly introduce the more traditional organizations forms (Galbraith, 2012), including functional, divisional and matrix organizations as well as others such as autonomous teams, networks and virtual organizations.
Functional organizations are arranged according to particular functional areas and this approach to managing organizations has existed for many years.  Resources are grouped according to the function (such as engineering, marketing, sales, strategy and so on) and in certain cases this type of structure can be efficient as there is a high level of specialism within each function.  However, there can also be difficulties in coordination and collaboration across functions leading to a lack of flexibility and adaptability to change.  Functional organizations are most suited to high volume, low cost companies where standardization allows, for example, the manufacture of consumer goods to be undertaken in a low margin business environment.  
Divisional organizations are arranged according to defined divisions, which can be product or service oriented or geographic.  Each division can potentially operate as a standalone business within the company with divisional performance measured and tracked.  The company’s divisions will contain the required functional areas in order to support delivery of the division’s products or services.  Divisional organizations can have flexibility to respond to emerging requirements and external threats as there is the ability to modify and adapt the division in response to such changes.  However, this organizational form can lead to the duplication of management roles across all the divisions and there can also be unnecessary competition between different divisions.  
Matrix organizations involve delivery according to a project or product area and allow groups of individuals from different functions or departments/divisions to come together to support delivery of the project or product.  Matrix organizations can be dynamic as they are able to readily reconfigure in order to allow new projects or product developments to be pursued.  Such organizations also avoid the ‘stove piped’ approach that can often be associated with functional organizations.  In these organizations there will often be a matrix team manager tasked with delivering the project or product area as well as functional or resource managers responsible for the management of human resources.   However, matrix organizations can lead to difficulties associated with which manager within the organization has overall leadership responsibility.  Consequently, matrix team members may have divided loyalties between the matrix team manager and the functional or resource manager and this can sometimes lead to conflict between management as well as there being competing demands on limited resources.  
Other organizational forms include autonomous teams, networks and virtual organizations.  Autonomous teams can involve self-managing teams within an organization working to deliver a particular organizational product or service.  Networks can be configured to include several organizations working together, or workers from different organizations coming together.  Virtual organizations involve partnerships or alliances between different organizations, teams or people and such an organization would not necessarily need to have a distinct physical presence of its own but instead exist virtually (i.e. operating via an electronic or online presence).
In terms of responding to changes in the external environment, which include technological, legislative, international and competitive dynamics, Lewin et al. (1999) maintain that companies will undergo change both on a strategic orientation and organizational basis in order to remain competitive.  In related work, Heydebrand (1989) commented that “New organizational forms are emerging in identifiable ways and they are largely the result of the transition from industrial to post-industrial capitalism”.  Moreover, if we consider the historical view from Schumpeter (1950) that “The problem that is usually visualised is how capitalism administers existing structures, whereas the relevant problem is how it creates and destroys them”, we can see the literature points to a continued emergence of  modified and new organizational forms.  Returning then to our arising hypothesis, which is that new organizational forms will emerge in response to the increasing complexity of technologies and engineering systems, it is therefore useful to explore two cases in detail in order to assess whether new organizational forms are indeed emerging.   Consequently, this paper will examine the case for open innovation and crowdsourcing, which are currently two of the most high-profile technology and innovation business models being pursued.   

Overview of Open Business Models
Open innovation as a concept was originally developed and articulated by Henry Chesbrough, who provided the following definition: “Open innovation means that valuable ideas can come from inside or outside the company and can go to market from inside or outside the company as well” (Chesbrough, 2006).  Essentially this relates to the flow of knowledge and ideas both into and out of an organization.  Closed innovation would therefore relate to situations where companies generate and develop their owns ideas, without relying on external input or equally without transferring internal sourced innovations to external parties for development.  Exhibit 1 provides a schematic view of the open innovation model from research, development through to commercialization stages, where the transfer of research and technology ideas and projects both into and out of the company effectively increases the number of commercial opportunities under development in the company’s innovation funnel or pipeline.

Exhibit 1. Open innovation model, adapted from Chesbrough, Vanhaverbeke and West (2006).


	The wide availability of data and information, the pace of change especially associated with ICT (information and communications technology) as well as the global basis for competition between industrial firms have ultimately given rise to the need for companies to no longer rely solely on innovation from internal sources.  Potential advantages offered by the open innovation approach include reduced R&D (research and development) costs, access to a larger set of innovation capabilities, earlier integration of external innovations and customer requirements in the product development lifecycle that all collectively contribute to improved productivity.  However, potential disadvantages include the possibility of organizations losing control of valuable intellectual property (IP) and an increased complexity associated with delivery across multiple organizations.
	A high-profile example of the adoption of open innovation is Procter & Gamble’s (P&G) ‘Connect and Develop’ programme (Chesbrough, 2007), which acquires either products from partner companies or licenses technologies from them in order to contribute to the development of P&G branded products.  Successes through this approach have been attributed to the company’s Crest SpinBrush and Olay Regenerist products and the initiative continues to source external concepts and technologies through a distributed network of technology scouts.  A further example of open innovation is IBM’s movement away from using a proprietary operating system to its support of the open source Linux operating system, which allowed the company to significantly reduce development costs but it also managed to retain influence over the operating system and contribute to its technical trajectory.  Moreover, West and Gallagher (2006) have explored the role of open innovation in the open source software industry and identified four main strategies employed by firms in the sector, which are as follows: pooled R&D product development, spinouts, selling complements and attracting donated complements.
	As an open business model crowdsourcing can be viewed as a complementary approach to open innovation.  The term crowdsourcing was originally coined by Jeff Howe and Mark Robinson in the June 2006 issue of Wired Magazine (Howe, 2006): “Crowdsourcing describes a new web-based business model that harnesses the creative solutions of a distributed network of individuals through what amounts to an open call for proposals” (Brabham, 2006).  Crowdsourcing can involve the online sourcing of resources and labor to contribute to a company’s business or it can also involve the related area of crowdfunding where capital for investment in new ideas, technologies, products or even businesses can be secured from an online pool of investors.  Furthermore, design crowdsourcing is the process of commissioning product design work online from a community of providers (the crowd) for a defined set of product requirements. The overall crowdsourcing market has been growing at a significant rate (MassulationTM, 2012), rising from $140m in 2009 to $215m in 2010 and increasing further to $375m in 2011 (Exhibit 2). This trend is expected to continue with the business model being adopted in different sectors and applications. 

Exhibit 2. Crowdsourcing market revenue growth 2009-11. Source: MassulationTM, 2012.

	Doan et al. (2011) have described how crowdsourcing systems rely on the inputs of many individuals, with the Wikipedia information website and the Linux operating system being widely known examples of such systems.  The authors also describe how the crowd are enlisted to effectively solve four fundamental challenges, which are: How to recruit and retain users? What contributions can users make? How to combine user contributions to solve the target problem? How to evaluate users and their contributions?  Leveraging ideas and expertise from the crowd allows companies to gain access to a potentially massive pool of expertise that is often distributed globally and managed through a commercial online crowdsourcing platform.




Open Innovation in the Pharmaceutical Industry
The pharmaceutical sector faces a number of major challenges (Garnier, 2008), which include: Declining profitability, decreasing growth prospects, revenue losses due to key patent expirations (and resulting competition with generics manufacturers), more demanding global regulatory requirements as well as a loss in shareholder value (estimated at $850billion between 2000 to 2008).  Within this industrial sector and from a research and development (R&D) perspective, a key measure of success is the ability to secure approval of new molecular entities (NMEs), which are first-in-class drug molecules that have previously not been approved by the appropriate regulator, such as the US FDA (Food and Drug Administration).  A further feature of the pharmaceutical sector is that despite a continuing trend of increasing R&D investments, there is a lower level of NME approvals being observed (see Exhibit 3), which indicates an apparent decreasing level of R&D productivity.

Exhibit 3.  Number of FDA NME approvals and US R&D pharmaceutical expenditure, 2006-11. 
Sources: Mullard, 2014 and PhRMA, 2013.


The development of new drug compounds can be viewed as part of a lifecycle that starts in the drug discovery stage, followed by pre-clinical and then clinical trials (phases I, II and III) and finally marketing (phase IV).  Exhibit 4 provides a schematic view of this drug development lifecycle, which further illustrates the scale of challenges associated with bringing a new drug compound to market as well as the substantial costs, which can be up to US$1.8billion for each new drug compound.  In this context the industry is being driven to adopt new business models (Philbin, 2013) that will restore R&D productivity levels and also generate the required level of NME approvals to maintain competitiveness in the globalized pharmaceutical sector.   
In recent years there has been a shift in the pharma industry, where an increasing level of industrial activity is being outsourced, e.g. genomics services being undertaken by specialist providers to big pharma and biotech companies (Karow, 2013).  This outsourcing approach allows pharmaceutical companies to gain access to a wider set of technical capabilities beyond those within the company and also provides access to a greater pool of potential NME approvals.   Furthermore, pharmaceutical companies are increasingly pursuing an open innovation agenda through adopting different organizational modes, such as licensing agreements, non-equity alliances as well as the purchase and supply of technical and scientific services (Bianchi et al., 2011).  Such partnerships have been established between big pharma and biotech firms, independent research institutes, hospitals and universities; they essentially provide additional innovation channels for the pharmaceutical companies to leverage.





The CTI (Centers for Therapeutic Innovation) open innovation partnership model adopted by Pfizer (Ratner, 2011) in USA involves investment into academic clusters targeted towards a specific therapeutic area, such as monoclonal antibodies.  These investments are attractive to pharmaceutical companies for a number of reasons, namely they are focused on bringing industrial research closer to academic capabilities in order to improve the drug identification and development process.  Joint programs with industry are also attractive to universities as they can help fulfil the core academic mission of translating basic medicine research into the healthcare arena through gaining access to industrial compound libraries and technical capabilities for advanced research.  Such programs can also provide substantial resources and associated funding for academic institutions.  
Pfizer contracts and funds the CTI initiatives according to a pre-negotiated template agreement with each academic institution and the company funds a small team of researchers at the university who work alongside a co-located industrial team.  A joint university-industry steering committee approves project proposals and also administers additional funds for further biology studies to take forward promising candidate drug compounds to early phase trials.  The scheme includes two clinical milestone payments, with the first one at the proof of mechanism stage and the second one at the proof of concept stage.  All invention submissions are jointly owned with Pfizer having an exclusive option to license arising IP for a new drug compound.  In the scenario where Pfizer does not exercise the option, the university is able to pursue license opportunities with third-party organizations.
In order to highlight the key features of the organizational form for this application of open innovation in the pharmaceutical sector, Exhibit 5 provides a summary of the characteristics according to four main categories. 

Exhibit 5.  Summary of organizational form adopted to support open innovation in pharmaceutical industry.

Category	Characteristics
(1). Structure	Project-based teams managed through open innovation approach and across organizational boundaries with multiple reporting lines.Joint university-industry steering committee overseeing development and progress of the initiative.  Principal investigators from university report to steering committee in addition to existing university departmental structures.  Industrial co-located scientists reporting to principal investigators and also having company-based management and reporting lines.
(2). Processes	Governance process associated with joint steering committee but with additional governance from host academic department as well as industrial oversight.  Project development process requiring technical inputs.  Project review and approval process (administered through steering committee).  Commercial management processes, including intellectual property considerations, contractual performance review and progress against drug development milestones.
(3). Resources	Supervising academic staff (principal investigators) and post-doctoral researchers funded by company at university.Co-located industrial scientists at university working alongside academic researchers.Senior management on steering committee as well as involvement of university department chair and senior industrial leadership positions.
(4). Infrastructure	Biomedical research laboratories, ICT infrastructure and knowledge-based software systems located at university.Pharmaceutical databases and compound libraries provided by company (in electronic format).

Having considered how open innovation has been adopted in the pharmaceutical industry it is possible to derive the pros and cons for this application of the open business model, which are provided in Exhibit 6.

Exhibit 6.  Pros and cons for open innovation in pharmaceutical industry.

Pros	Cons
There can be close and integrated collaboration developed between the company and university.	There may be uncertainty over whether industrial or academic priorities take precedence.
Joint working results in rapid and efficient sharing of research findings.	There may be uncertainty over who has ultimate responsibility for the research direction.
The pharmaceutical company secures direct access to clinical specimens for biomedical research.	The ability of the university to retain academic creativity and independence could potentially be compromised.
The university gains direct access to pharmaceutical compound libraries.	The ability of the company to retain an industrial focus could potentially be compromised.
This approach supports the translation of basic research into industrial applications (i.e. commercial technology transfer).	It is not clear whether the commercial framework will ultimately support a robust allocation of intellectual property rights that is agreeable to both parties.

Product Design through Crowdsourcing
The product design sector has like many other industries been subject to increasing pressure on margins, reduced engineering cycle times and the constant need for greater efficiencies in the supply chain, whether products are being designed and manufactured for automotive, aerospace, construction, defense or other such engineering sector.  The product lifecycle (Andrew et al., 2013) can be viewed as commencing with idea generation and product selection, followed by product development and then realization (see Exhibit 7).  
In terms of improving the performance of the pre-launch stage of the lifecycle there are two options: To reduce the time taken to develop the product (i.e. to reduce the time-to-market), or to reduce the level of investment required to reach product launch (i.e. to reduce the pre-launch investment).  Traditionally when designing new products, manufacturers need to balance higher development costs associated with reducing time-to-market with the potential greater market share achieved by being in the marketplace at an earlier point.  There is also a need to consider the time required to reach volume production (time-to-volume) in order to deliver payback of the investment as well as scope for any product extensions.
Designing products through a crowdsourcing approach can be positioned as a strategy to allow manufacturers to potentially improve performance of the product lifecycle since there is scope to both reduce the time-to-market and also potentially reduce the level of pre-launch investment.  As competition increases on both national and international levels and companies have to compete on quality in addition to having cost reduction and lean manufacturing initiatives to implement, there is greater interest in exploring alternative approaches (such as crowdsourcing), which have the potential to enhance industrial competitiveness, e.g. in terms of first-to-market advantages.  
Exhibit 8 provides a schematic view of product design through a crowdsourcing approach.  In this illustrative scheme the client has a set of design requirements to be fulfilled and the crowd provides the design solutions to address the product brief with the process being facilitated by the online commercial platform, which acts as the knowledge exchange and financial transaction channel to underpin the overall process.  The scheme also includes five main stages that have been identified as part of the process.  Example applications include the design of new household consumer products, or graphic design work to support a company’s marketing campaign.









Poetz and Schreier (2012) have described the benefits arising from firms engaging a crowd of users to provide product ideas and this study identified that the solutions generated via a crowdsourcing approach can have the same level of novelty and customer benefit when compared to solutions provided by design professionals employed within the firm engaged through traditional NPD (new product development) activities.  Although the study did reveal that crowdsourced solutions tend to have a lower level of feasibility when compared to the NPD solutions.  Nevertheless this work illustrates the potential for crowdsourcing to be applied to product design.  Dell’s IdeaStorm community is a further platform used for sourcing innovation and product ideas from the crowd (Bayus, 2013).  An implication of the crowdsourcing approach where the crowd participates through ideation, feedback and voting as part of the innovation process can be a lack of collaborative discourse leading to co-creation (Majchrzak and Malhotra, 2013), although this may be mitigated through improved technologies allowing greater levels of participation by members of the crowd. 
In order to highlight the key features of the organizational form for the application of crowdsourcing in the product design sector, Exhibit 9 provides a summary of the characteristics according to four main categories. 

Exhibit 9.  Summary of organizational form adopted to support product design through crowdsourcing.

Category	Characteristics
(1). Structure	Product-based teams are managed through open innovation approach and across organizational boundaries with multiple reporting lines.Sponsor from the client organization managing product design process and reporting as part of matrix structure in industrial company.Designers are contracted through crowdsourcing platform are independent agents (likely to be either in a small company or sole traders).Service company is responsible for management and administration of the platform (which could be a venture capital backed start-up company).
(2). Processes	Technical design process with input from client and design community (crowd) through an iterative process facilitated by platform.Transaction and payment process providing funds to designers and commercial platform company.Marketing processes and profile raising activities carried out by platform in order to attract both clients and designers.
(3). Resources	Commercial platform resourcing, including management, administration and software engineering specialists responsible for platform architecture, maintenance and support functions.Sponsor and lead representative from client organization (technical or management staff).Distributed community of designers (the crowd) with various skills being geographically dispersed and from highly different backgrounds.  Designers are motivated according to their own independent agenda and are not part of the client’s immediate sphere of influence or control.
(4). Infrastructure	Crowdsourcing company facilities (office and headquarters’ functions).Crowdsourcing commercial platform (web-based).Design and software systems operated by client organization.Design and software systems operated by designers (which again will be highly variable configurations).

	The invention company Quirky (Digout, 2013) provides a commercial marketplace and online platform to facilitate interaction between the crowd and Quirky’s product design staff.  Ideas are submitted by the online community to Quirky, which then appraises, critiques and finally votes on submitted ideas.  Some of the ideas that receive a high vote are transitioned to Quirky’s design team and ultimately manufactured and sold online as well as in stores.  This is a further illustrative example of the growing trend towards product ideation and design that is delivered and managed through crowdsourcing.  Indeed in 2013 Quirky entered into a strategic partnership with GE (Sterling, 2013), which will license hundreds of its patents to Quirky’s community and then subsequently work directly with them in order to demonstrate and commercialize promising consumer applications of these patents.  The focus on consumer products means there is a clear distinction between this new business venture and GE’s traditional business areas, such as the manufacture of power plant turbines and medical imaging equipment.
Having considered how crowdsourcing has been adopted in the product design sector it is possible to derive the pros and cons for this application of the open business model, which are provided in Exhibit 10.

Exhibit 10.  Pros and cons for product design through crowdsourcing.

Pros	Cons
The approach can be a lower cost option since the work is being outsourced and so in-house design staff not needed.	The quality of design submissions can be highly variable, although this will depend on the clarity of requirements and level of payment offered.
Engaging a crowd of designers can result in a large number of design submissions being generated therefore enabling a wider selection of designs to be considered.	The open approach and lack of confidentiality may result in difficulties in regard to intellectual property considerations and how sensitive product information is handled.
Design process can be faster since there is a pre-assembled crowd of designers available to be engaged electronically through the crowdsourcing platform.	The crowdsourcing process can lack the necessary degree of collaboration that is often a feature of innovative and successful design.
Designers are not encumbered by previous plans or approaches to the product and therefore creative solutions and new concepts are optimized.	There may be a potential need to search through many (even thousands) of design submissions.

Conclusions
New business models will continue to emerge and this leads to new, improved, enhanced, or even unconventional organizational forms also emerging, which is consistent with Schumpeter’s view on ‘creative destruction’ (1950).  Traditional organizational forms, such as functional, divisional and matrix organizations will of course continue to be applicable in many organizational circumstances but open business models do not appear to readily fit into such existing organizational structures.  Moreover, open business models can be viewed as simultaneously having the characteristics of several organizational forms.  Industrial companies looking to develop new technologies through open channels may operate through matrix project-based teams but they will also be connected to multiple virtual and networked organizations through the strategic and sometimes ad hoc alliances adopted as part of the innovation process and product development lifecycle. 
Open innovation in the pharmaceutical industry represents a significant development and new direction for big pharma companies, which potentially offers benefits in terms of improving the drug development process and ultimately leading to a greater number of NME approvals.  Partnering with universities through an open innovation model would appear to be a new organizational form when compared to traditional collaboration between pharmaceutical companies and universities.  There can be benefits in regard to allowing industrial teams co-locate with academic researchers, providing academic institutions with paid access to industrial compound libraries and also providing industrial companies with direct access to academic capabilities and biological specimens.  However, there could be significant organizational and governance challenges as well as commercial issues associated with the downstream allocation of intellectual property rights (IPR).  Nevertheless this application of the open business model provides a promising channel for the pharmaceutical industry to underpin future drug development initiatives. 
Product design through a crowdsourcing approach represents a significant development for companies engaged in the ideation, development, manufacture and marketing of new products across a range of industries.  Accessing such a geographically distributed as well as diverse network of suppliers would also appear to be a new organizational form.  Indeed compared to a traditional NPD approach, it can be a radically different way to engage the services of a large number of product designers and at a comparatively low cost whilst also being rapid.  However, are the designs that are submitted of the required quality and will the business model prove to be sustainable beyond the initial rounds of VC (venture capital) backing that many of the crowdsourcing companies have received?  Despite these concerns this application of the open business model also provides a promising channel for companies to explore in order to improve efficiencies and innovation in product development.
Future work is suggested on identifying management frameworks to support open innovation business models.  Open innovation and crowdsourcing approaches potentially increase the complexities of industrial processes, since there is a greater need for managing across organizational boundaries as well as other commercial considerations, e.g. in regard to the management of IPR.  Consequently, it is suggested that research is carried out to explore further these complexities and to develop management techniques to support organizations and managers involved in such open business models.
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